Norge - norsk - Statens legemiddelverk

mylan ab - amlodipinbesilat / valsartan / hydroklortiazid - tablett, filmdrasjert - 5 mg / 160 mg / 25 mg

Norge - norsk - Statens legemiddelverk

mylan ab - amlodipinbesilat / valsartan / hydroklortiazid - tablett, filmdrasjert - 10 mg / 160 mg / 25 mg

Norge - norsk - Statens legemiddelverk

mylan ab - amlodipinbesilat / valsartan / hydroklortiazid - tablett, filmdrasjert - 10 mg / 320 mg / 25 mg

Norge - norsk - Statens legemiddelverk

sandoz (2) - losartankalium / hydroklortiazid - tablett, filmdrasjert - 100 mg / 12.5 mg

Norge - norsk - Statens legemiddelverk

orifarm as - irbesartan / hydroklortiazid - tablett - 300 mg / 25 mg

Norge - norsk - Statens legemiddelverk

teva b.v. - bupropionhydroklorid - tablett med modifisert frisetting - 150 mg

Norge - norsk - Statens legemiddelverk

teva b.v. - bupropionhydroklorid - tablett med modifisert frisetting - 300 mg

Den europeiske union - norsk - EMA (European Medicines Agency)

novartis europharm limited - vildagliptin, metformin hydrochloride - diabetes mellitus, type 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 og 5. 1 for tilgjengelige data på forskjellige kombinasjoner).

Norge - norsk - Statens legemiddelverk

orifarm as - kolesevelam - tablett, filmdrasjert - 625 mg

Norge - norsk - Statens legemiddelverk

orion corporation - espoo - kandesartancileksetil / hydroklortiazid - tablett - 8 mg / 12.5 mg